ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,000 | -43.3% | 224,900 | -9.8% | 0.00% | -50.0% |
| Q2 2022 | $67,000 | -61.3% | 249,400 | -19.4% | 0.00% | -33.3% |
| Q1 2022 | $173,000 | -20.3% | 309,400 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $217,000 | +45.6% | 309,400 | +238.5% | 0.00% | +33.3% |
| Q3 2021 | $149,000 | -49.8% | 91,400 | -38.7% | 0.00% | -40.0% |
| Q2 2021 | $297,000 | -47.6% | 149,000 | -12.8% | 0.01% | -54.5% |
| Q1 2021 | $567,000 | -16.6% | 170,800 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $680,000 | +47.2% | 170,800 | -2.8% | 0.01% | +27.3% |
| Q3 2020 | $462,000 | -13.3% | 175,800 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $533,000 | +183.5% | 175,800 | +83.3% | 0.01% | +175.0% |
| Q1 2020 | $188,000 | -79.7% | 95,900 | -23.8% | 0.00% | -66.7% |
| Q4 2019 | $927,000 | – | 125,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,950,949 | $1,092,000 | 0.45% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $829,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 158,900 | $86,000 | 0.06% |
| Atom Investors LP | 113,151 | $63,000 | 0.03% |
| Nantahala Capital Management | 774,767 | $434,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,173,000 | 0.02% |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $659,000 | 0.01% |
| Altshuler Shaham Ltd | 1,088,848 | $609,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 309,400 | $173,000 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $328,000 | 0.00% |